|Articles|January 20, 2023
T Cell expansion in the DASbox® Mini Bioreactor System
Author(s)Eppendorf
This application note examines the suitability of BioBLU® 0.3c Single-Use Bioreactors and the DASbox Mini Bioreactor System in the long-term expansion of CD4+ T cells.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Novel Delivery Approaches of Biopharmaceuticals 2025
2
Samsung Biologics Bolsters US Manufacturing Network with GSK Facility Buy
3
FAQ: What You Need to Know about the Current Antibody Pipeline
4
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
5